These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 20440118)

  • 1. The role of liver iron in hepatitis C antiviral treatment.
    Musallam KM; Sharara AI; Inati A; Taher AT
    Eur J Gastroenterol Hepatol; 2010 Jun; 22(6):769. PubMed ID: 20440118
    [No Abstract]   [Full Text] [Related]  

  • 2. Safety and efficacy of pegylated interferon alpha-2a and ribavirin for the treatment of hepatitis C in patients with thalassemia.
    Harmatz P; Jonas MM; Kwiatkowski JL; Wright EC; Fischer R; Vichinsky E; Giardina PJ; Neufeld EJ; Porter J; Olivieri N;
    Haematologica; 2008 Aug; 93(8):1247-51. PubMed ID: 18556414
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Treatment with pegylated interferon and ribavirin in patients co-infected by human immunodeficiency virus and hepatitis C virus].
    Marcos Sánchez F; Albo Castaño MI; Casallo Blanco S
    Rev Clin Esp; 2007 Mar; 207(3):150-1; author reply 151-2. PubMed ID: 17397643
    [No Abstract]   [Full Text] [Related]  

  • 4. [Hepatitis C].
    Pache I; Gonvers JJ
    Rev Med Suisse Romande; 2002 Oct; 122(10):507-12. PubMed ID: 12494784
    [No Abstract]   [Full Text] [Related]  

  • 5. Peginterferon alfa-2b and ribavirin in thalassaemia/chronic hepatitis C virus-co-infected non-responder to standard interferon-based.
    Hamidah A; Thambidorai CR; Jamal R
    Med J Malaysia; 2005 Oct; 60(4):517-9. PubMed ID: 16570722
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PegIFN/ribavirin during acute HCV coinfection.
    Bernard EJ
    IAPAC Mon; 2004 Jul; 10(7):260-1. PubMed ID: 15624247
    [No Abstract]   [Full Text] [Related]  

  • 7. Pegylated interferon-alpha2a and ribavirin in HIV-hepatitis C coinfected patients.
    Expert Rev Anti Infect Ther; 2004 Jun; 2(3):341-2. PubMed ID: 15490503
    [No Abstract]   [Full Text] [Related]  

  • 8. [HIV/HCV double infection: combination is a clear therapy option].
    Reich B
    Dtsch Med Wochenschr; 2004 Jul; 129(28-29):1590. PubMed ID: 15274242
    [No Abstract]   [Full Text] [Related]  

  • 9. Second thoughts about secondary analyses.
    Ferenci P
    Dig Liver Dis; 2005 Oct; 37(10):805-7; author reply 808-9. PubMed ID: 16023903
    [No Abstract]   [Full Text] [Related]  

  • 10. FDA approves Pegasys and Copegus for hepatitis C in patients with HIV co-infection.
    Bartlett JG
    Hopkins HIV Rep; 2005 May; 17(3):15. PubMed ID: 16419314
    [No Abstract]   [Full Text] [Related]  

  • 11. Pegylated interferon and ribavirin in real life: efficacy versus effectiveness.
    de Mattos AZ; de Almeida PR; Tovo CV; de Mattos AA
    Hepatology; 2010 Nov; 52(5):1867. PubMed ID: 20726033
    [No Abstract]   [Full Text] [Related]  

  • 12. Scleromyxedema secondary to hepatitis C virus and successfully treated with antiviral therapy.
    Smith JA; Kalimullah FA; Erickson CP; Peng LS
    Dermatol Online J; 2015 Sep; 21(9):. PubMed ID: 26437283
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Seventy-two weeks of peginterferon and ribavirin for patients with partial early virologic response?
    Hoefs JC; Morgan TR
    Hepatology; 2007 Dec; 46(6):1671-4. PubMed ID: 18046713
    [No Abstract]   [Full Text] [Related]  

  • 14. Hepatitis drug gets approval for coinfection treatment.
    AIDS Patient Care STDS; 2005 May; 19(5):351. PubMed ID: 15916498
    [No Abstract]   [Full Text] [Related]  

  • 15. [Primer treatment of acute and chronic hepatitis C].
    Daruich J; Fainboim H; Frider B
    Acta Gastroenterol Latinoam; 2006 Jun; 36 Suppl 1():S52-6; discussion S74-82. PubMed ID: 16862862
    [No Abstract]   [Full Text] [Related]  

  • 16. Predictors of response of U.S. veterans to treatment for the hepatitis C virus.
    Riley TR
    Hepatology; 2008 Jan; 47(1):356; author reply 356-7. PubMed ID: 18161713
    [No Abstract]   [Full Text] [Related]  

  • 17. Treatment of HBV/HCV coinfection: releasing the enemy within.
    Gordon SC; Sherman KE
    Gastroenterology; 2009 Feb; 136(2):393-6. PubMed ID: 19105960
    [No Abstract]   [Full Text] [Related]  

  • 18. [Long-acting interferon: studies on pegylated interferon].
    Ma H; Wang H
    Zhonghua Gan Zang Bing Za Zhi; 2002 Feb; 10(1):78-9. PubMed ID: 11856520
    [No Abstract]   [Full Text] [Related]  

  • 19. Insulin resistance and HCV virologic response to peg-interferons (Peg-IFN) with ribavirin (RBV) in HIV/HCV co-infected patients.
    Donato C; Cingolani A; Pinnetti C; De Luca A
    J Hepatol; 2010 Feb; 52(2):306-7. PubMed ID: 20006404
    [No Abstract]   [Full Text] [Related]  

  • 20. Hepatitis C treatment, HAART and side effects.
    TreatmentUpdate; 2001; 13(7):7-8. PubMed ID: 11794865
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.